EE249 Cost-Utility Analysis of Benralizumab in Severe Eosinophilic Asthma in Costa Rica

Abstract

Authors

J Ordoñez R Guadamuz O Monge A Ordóñez J Hidalgo Godínez R Buitrago

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×